Latest / The Dales Report | Trade to Black
MediPharm Labs Faces Boardroom Showdown: Apollo Capital Pushes for Change
Shadd Dales takes a closer look at the growing tension between MediPharm Labs (TSX: LABS) and one of its largest independent shareholders, Apollo Technology Capital Corporation.Apollo, which holds nearly 3% of MediPharm’s shares, is pushing for major change after the company posted its 21st consecutive quarterly loss. With only $8.4 million in cash and over $3.3 million burned in Q1 alone, Apollo believes the company could run out of money by November 2025. They’re also pointing to declining revenues, especially in international and Canadian adult-use markets, and what they see as a lack of a…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.